Purchase textbook

Drug Discovery and Development,

Edition 3 Technology in Transition

Editors: Edited by Raymond G. Hill and Duncan Richards, MA DM FRCP FFPM FBPharmacolS

Publication Date: 24 Aug 2021

0 Reviews

Conformance

PDF/UA-1
The publication was certified on 20250625
For queries regarding accessibility information, contact [email protected]

Ways Of Reading

This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation.

Navigation

The contents of the PDF have been tagged to permit access by assistive technologies as per PDF-UA-1 standard.
Page breaks included from the original print source

Additional Accessibility Information

The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.

Note

This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.

With unprecedented interest in the power that the modern therapeutic armamentarium has to combat disease, the new edition of Drug Discovery and Development is an essential resource for anyone interested in understanding how drugs and other therapeutic interventions are discovered and developed, through to clinical research, registration, and market access.

The text has been thoroughly updated, with new information on biopharmaceuticals and vaccines as well as clinical development and target identification. Drug discovery and development continues to evolve rapidly and this new edition reflects important changes in the landscape.

Edited by industry experts Raymond Hill and Duncan Richards, this market-leading text is suitable for undergraduates and graduates undertaking degrees in pharmacy, pharmacology, toxicology, and clinical development through to those embarking on a career in the pharmaceutical industry.

Key Features

Key stages of drug discovery and development
Chapters outline the contribution of individual disciplines to the overall process
Supplemented by specific chapters on different modalities
Includes coverage of Oligonucleotide therapies; cell and gene therapy
Now comes with online access on StudentConsult

About the author

Edited by Raymond G. Hill, President, British Pharmacological Society, London, UK and Duncan Richards, MA DM FRCP FFPM FBPharmacolS, St Hilda’s College, Oxford, UK

Section 1 Introduction and Background
1. Development of the pharmaceutical industry
2. Nature of disease and purpose of therapy
3. Therapeutic modalities

Section 2 Drug Discovery
4. Drug target identification
5. Selecting the modality and planning the project
6. High throughput screening
7. Medicinal Chemistry
8. Biopharmaceuticals and related molecules
9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process
10. Metabolism and Pharmacokinetical strategies.
11. Role of pharmacology to include pharmacology of newer modalities
12. In vitro in vivo translation
13. Vaccines

Section 3 Drug Development
14. Drug development introduction
15. Drug safety
16. Pharmaceutical development
17. Clinical development
18. Clinical imaging
19. Intellectual property
20. Regulatory affairs
21. Marketing and Patient access to medicines

Section 4 Facts and Figures
22. Facts and Figures; and the Future

Drug Discovery and Development,

Editors: Edited by Raymond G. Hill and Duncan Richards, MA DM FRCP FFPM FBPharmacolS

Description

Key Features

About the author